Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Claudio Norbiato
Observed names:
C Norbiato,
Norbiato Claudio
Institution:
A. O. Ordine Mauriziano di Torino
Observed institutions:
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia,
A. O. Ordine Mauriziano di Torino,
University of Turin,
University of Brescia
ORCID:
0000-0003-0508-0460
Observed ORCID:
0000-0003-0508-0460
OpenAlex ID:
A5064604203
Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial
2020
·
Carlo Salvarani
, Giovanni Dolci
, et al.
·
JAMA Internal Medicine
·
773
PDF
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial
2020
·
Francesco Perrone
, Maria Carmela Piccirillo
, et al.
·
Journal of Translational Medicine
·
149
PDF
Low ADAMTS 13 plasma levels are predictors of mortality in COVID-19 patients
2020
·
Mario Bazzan
, Barbara Montaruli
, et al.
·
Internal and Emergency Medicine
·
98
PDF
Antiphospholipid Antibodies and Infection: Non Nova Sed Nove
2021
·
Savino Sciascia
, Massimo Radin
, et al.
·
Frontiers in Immunology
·
33
PDF
Convalescent or standard plasma versus standard of care in the treatment of COVID-19 patients with respiratory impairment: short and long-term effects. A three-arm randomized controlled clinical trial
2022
·
Paola Maria Manzini
, Giovannino Ciccone
, et al.
·
BMC Infectious Diseases
·
14
PDF
Acquired Factor XI Deficiency during SARS-CoV-2 Infection: Not Only Thrombosis
2020
·
Giacomo Andreani
, Lorenzo Uscello
, et al.
·
TH Open
·
14
PDF
Real-world use of remdesivir for the treatment of patients admitted to Italian hospitals with COVID-19: the nationwide retrospective FADOI-RECOVER study
2023
·
Filippo Pieralli
, Fulvio Pomero
, et al.
·
BMC Infectious Diseases
·
5
PDF
Risk factors of SARS‐CoV ‐2 seroprevalence among hospital employees in Italy: a single‐centre study
2021
·
Marco Daperno
, Cristina Guiotto
, et al.
·
Internal Medicine Journal
·
3
PDF
COPD, but Not Asthma, Is Associated with Worse Outcomes in COVID-19: Real-Life Data from Four Main Centers in Northwest Italy
2022
·
Stefania Nicola
, Richard Borrelli
, et al.
·
Journal of Personalized Medicine
·
1
PDF
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial
2021
·
Francesco Perrone
, Maria Carmela Piccirillo
, et al.
·
Journal of Translational Medicine
·
1
PDF
Macrophage Activation Syndrome Following Atezolizumab in Advanced Non-Small-Cell Lung Cancer: A Case Report
2026
·
Andrea Caglio
, Emma Pisciotta
, et al.
·
Onco
Hemodynamic forces analysis using transthoracic echocardiogram in acute heart failure
2023
·
V Vassia
, S Pantaleoni
, et al.
·
European Heart Journal
PDF
Addressing the treatment of macrophage activation syndrome: A challenging balance between immune suppression and infectious risk
2022
·
V Vassia
, A Iannaccone
, et al.
·
Global Journal of Infectious Diseases and Clinical Research
PDF
Analysis of the characteristics of patients admitted to Internal Medicine wards for exacerbation of chronic obstructive pulmonary disease, and discharge phase optimization. The SDO-ARCA Project of the Scientific Society FADOI
2020
·
Marco Candela
, Claudio Norbiato
, et al.
·
Italian Journal of Medicine
PDF
SARS-CoV-2 seroprevalence in hospital employees in Italy
2020
·
I. Casonato
, Marco Daperno
, et al.
·
Biochimica Clinica
SARS-2-Cov 2 induced coagulopathy: An antiphospholipid cohort study
2020
·
Barbara Montaruli
, M. Bazzan
, et al.
·
Biochimica Clinica
Show more works
View as search
Works count:
16
Citation count:
1,091
H-index:
6
I10-index:
6
Year
Topic
Type